Dr Singh Discusses Strategies & Collaboration in Radiation for SCLC

Small cell lung cancer is one of the most aggressive malignancies oncologists face: fast-moving, complex to treat, and rapidly evolving in its therapeutic landscape.

In this episode of The OncoloGIST, host Sabrina Serani sat down with Dr Raj Singh, radiation oncologist, to explore the current state of radiation therapy in small cell lung cancer, from the long-standing debate over twice-daily fractionation, to dose escalation strategies, to the landmark ADRIATIC trial and what it means for how we treat patients today.

Dr Singh also takes viewers inside the critical—and often underappreciated—role of multidisciplinary collaboration, discussing the logistical challenges of integrating radiation early in treatment, how to manage competing risks in extensive-stage disease, and the emerging role of radiosurgery in the management of brain metastases.

Whether you're a medical oncologist, radiation oncologist, or trainee navigating this space, this conversation offers a practical and forward-looking perspective on one of oncology's most challenging diseases.